BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1184 related articles for article (PubMed ID: 29421811)

  • 1. Swiprosin-1 Promotes Mitochondria-Dependent Apoptosis of Glomerular Podocytes via P38 MAPK Pathway in Early-Stage Diabetic Nephropathy.
    Wang RM; Wang ZB; Wang Y; Liu WY; Li Y; Tong LC; Zhang S; Su DF; Cao YB; Li L; Zhang LC
    Cell Physiol Biochem; 2018; 45(3):899-916. PubMed ID: 29421811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LY333531, a PKCβ inhibitor, attenuates glomerular endothelial cell apoptosis in the early stage of mouse diabetic nephropathy via down-regulating swiprosin-1.
    Wang ZB; Zhang S; Li Y; Wang RM; Tong LC; Wang Y; Liu WY; Su DF; Tu Y; Zhang LC; Li L
    Acta Pharmacol Sin; 2017 Jul; 38(7):1009-1023. PubMed ID: 28414198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TXNIP deficiency mitigates podocyte apoptosis via restraining the activation of mTOR or p38 MAPK signaling in diabetic nephropathy.
    Song S; Qiu D; Wang Y; Wei J; Wu H; Wu M; Wang S; Zhou X; Shi Y; Duan H
    Exp Cell Res; 2020 Mar; 388(2):111862. PubMed ID: 31982382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine 1 receptor activation protects mouse diabetic podocytes injury via regulating the PKA/NOX-5/p38 MAPK axis.
    Shao X; Zhang X; Hu J; Gao T; Chen J; Xu C; Wei C
    Exp Cell Res; 2020 Mar; 388(2):111849. PubMed ID: 31954110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thioredoxin-Interacting Protein Deficiency Protects against Diabetic Nephropathy.
    Shah A; Xia L; Masson EA; Gui C; Momen A; Shikatani EA; Husain M; Quaggin S; John R; Fantus IG
    J Am Soc Nephrol; 2015 Dec; 26(12):2963-77. PubMed ID: 25855771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of 12-lipoxygenase in the stimulation of p38 mitogen-activated protein kinase and collagen alpha5(IV) in experimental diabetic nephropathy and in glucose-stimulated podocytes.
    Kang SW; Natarajan R; Shahed A; Nast CC; LaPage J; Mundel P; Kashtan C; Adler SG
    J Am Soc Nephrol; 2003 Dec; 14(12):3178-87. PubMed ID: 14638916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Klotho plays a protective role against glomerular hypertrophy in a cell cycle-dependent manner in diabetic nephropathy.
    Oh HJ; Nam BY; Wu M; Kim S; Park J; Kang S; Park JT; Yoo TH; Kang SW; Han SH
    Am J Physiol Renal Physiol; 2018 Oct; 315(4):F791-F805. PubMed ID: 29638159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caspase-11/4 and gasdermin D-mediated pyroptosis contributes to podocyte injury in mouse diabetic nephropathy.
    Cheng Q; Pan J; Zhou ZL; Yin F; Xie HY; Chen PP; Li JY; Zheng PQ; Zhou L; Zhang W; Liu J; Lu LM
    Acta Pharmacol Sin; 2021 Jun; 42(6):954-963. PubMed ID: 32968210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes-Induced DUSP4 Reduction Promotes Podocyte Dysfunction and Progression of Diabetic Nephropathy.
    Denhez B; Rousseau M; Dancosst DA; Lizotte F; Guay A; Auger-Messier M; Côté AM; Geraldes P
    Diabetes; 2019 May; 68(5):1026-1039. PubMed ID: 30862678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Podocyte RNF166 deficiency alleviates diabetic nephropathy by mitigating mitochondria impairment and apoptosis via regulation of CYLD signal.
    Hongbo M; Yanjiao D; Shuo W; Kun S; Yanjie L; Mengmeng L
    Biochem Biophys Res Commun; 2021 Mar; 545():46-53. PubMed ID: 33545631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel podocyte protein, R3h domain containing-like, inhibits TGF-β-induced p38 MAPK and regulates the structure of podocytes and glomerular basement membrane.
    Ishikawa T; Takemoto M; Akimoto Y; Takada-Watanabe A; Yan K; Sakamoto K; Maezawa Y; Suguro M; He L; Tryggvason K; Betsholtz C; Yokote K
    J Mol Med (Berl); 2021 Jun; 99(6):859-876. PubMed ID: 33620517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Jixuepaidu Tang-1 inhibits epithelial-mesenchymal transition and alleviates renal damage in DN mice through suppressing long non-coding RNA LOC498759.
    Jin J; Zhang Z; Chen J; Liu Y; Chen Q; Wang Q
    Cell Cycle; 2019 Nov; 18(22):3125-3136. PubMed ID: 31564202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FR167653 inhibits fibronectin expression and apoptosis in diabetic glomeruli and in high-glucose-stimulated mesangial cells.
    Jung DS; Li JJ; Kwak SJ; Lee SH; Park J; Song YS; Yoo TH; Han SH; Lee JE; Kim DK; Moon SJ; Kim YS; Han DS; Kang SW
    Am J Physiol Renal Physiol; 2008 Aug; 295(2):F595-604. PubMed ID: 18524857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of TRPC6 Signal Pathway Alleviates Podocyte Injury Induced by TGF-β1.
    Huang H; You Y; Lin X; Tang C; Gu X; Huang M; Qin Y; Tan J; Huang F
    Cell Physiol Biochem; 2017; 41(1):163-172. PubMed ID: 28214865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emodin ameliorates high glucose induced-podocyte epithelial-mesenchymal transition in-vitro and in-vivo.
    Chen T; Zheng LY; Xiao W; Gui D; Wang X; Wang N
    Cell Physiol Biochem; 2015; 35(4):1425-36. PubMed ID: 25791065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes.
    Iglesias-de la Cruz MC; Ziyadeh FN; Isono M; Kouahou M; Han DC; Kalluri R; Mundel P; Chen S
    Kidney Int; 2002 Sep; 62(3):901-13. PubMed ID: 12164872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sirt6 Suppresses High Glucose-Induced Mitochondrial Dysfunction and Apoptosis in Podocytes through AMPK Activation.
    Fan Y; Yang Q; Yang Y; Gao Z; Ma Y; Zhang L; Liang W; Ding G
    Int J Biol Sci; 2019; 15(3):701-713. PubMed ID: 30745856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
    Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
    Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of TLR4 attenuates high glucose-induced podocyte injury via the NALP3/ASC/Caspase-1 signaling pathway.
    Liu Y; Xu Z; Ma F; Jia Y; Wang G
    Biomed Pharmacother; 2018 Nov; 107():1393-1401. PubMed ID: 30257355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced beta 2 glycoprotein I improves diabetic nephropathy via inhibiting TGF-β1-p38 MAPK pathway.
    Wang T; Chen SS; Chen R; Yu DM; Yu P
    Int J Clin Exp Pathol; 2015; 8(3):2321-33. PubMed ID: 26045739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.